Purity vs Net Peptide Content: Not the Same

A certificate can honestly report 99% purity for material that is nowhere near 99% peptide by weight. Those are not competing claims and neither one is a lie. They are two measurements taken against two different denominators, and a product page that prints one of them and stays quiet about the other is not necessarily hiding anything. It is simply reporting the test somebody paid for. This page is about what each number counts, what sits in the gap between them, and how far a purity figure can be pushed before it stops meaning what a reader assumes. It stops at label interpretation. It is educational context, not medical advice, and it gives no guidance about use of any kind.

Two numbers, two denominators

Chromatographic purity is a ratio among peaks. A peptide sample goes onto a column, the components come off at different times, an ultraviolet detector records them near 220 nm because the peptide bond absorbs strongly there, and purity is the area of the main peak divided by the total area of every peak. The denominator is everything the detector registered. Net peptide content answers a completely different question: of the total weight sitting on the balance, what fraction is peptide at all? The denominator there is the whole sample, including everything invisible to an ultraviolet detector. One number is about which peptides are present in what proportion. The other is about how much of the material is peptide rather than something else. Neither can be derived from the other, and a sample can be 99% pure by the first measure while being substantially less than 99% peptide by the second.^[6]

What the rest of the weight is

Three things generally occupy the gap. The first is the counterion. Trifluoroacetic acid, TFA, is the standard companion through solid-phase synthesis and reverse-phase purification, and trifluoroacetate ends up paired with the positively charged groups on the finished peptide: the N-terminus, and the side chains of lysine, arginine and histidine. A 2007 paper on removing it opens by stating flatly that trifluoroacetate is almost always present in commercially synthesised peptides. It is a real part of the weight, it does not absorb ultraviolet light usefully, and no chromatographic purity figure counts it. Quantifying it is a separate exercise again, typically anion-exchange ion chromatography with suppressed conductivity detection, which separates trace trifluoroacetate from the chloride, phosphate and other anions surrounding it. The second is water. Freeze-dried peptide is hygroscopic, so a residual moisture fraction travels with it, measured by a Karl Fischer method rather than by chromatography. In the published work behind pharmacopoeial peptide reference standards, residual moisture across the freeze-dried materials tested ran from 1.11% to 2.79% by weight, and those are reference standards whose values were assigned across multiple laboratories. The third is inorganic residue: sodium, chloride and other ions left behind by the process. In the glucagon study described below, all inorganic ions came in under 0.1% and could be set aside, which is a useful reminder that this component is usually the smallest of the three.^{[1, 2, 3, 5]}

The glucagon case, with numbers on both sides

The clearest published demonstration is a 2020 study in Scientific Reports in which metrologists at a national measurement institute set out to establish what a sample of synthetic glucagon actually contained. The manufacturer's stated purity was 98.4%. The authors ran the material by liquid chromatography with ultraviolet detection themselves and obtained a figure over 97%, close to what the manufacturer reported. Then they measured the sample a second way, by mass balance: quantify every non-peptide component separately and subtract. Trifluoroacetate, quantified by ion chromatography, came to 10.3% of the sample by weight. Water, by a Karl Fischer method, came to 5.0%. Peptide impurities were identified by Orbitrap mass spectrometry and quantified against nine independently synthesised reference peptides. The mass balance figure for glucagon content was 89.6%, against the manufacturer's 98.4%, a difference of roughly 8.7 percentage points. The authors put the discrepancy down to what a chromatographic figure structurally cannot count: some impurities do not absorb ultraviolet radiation, and others have absorption features overlapping the main constituent.^[1]

How net peptide content is actually established

There are two routes, and both are laborious. The first is quantitative amino acid analysis. The peptide is hydrolysed to its free amino acids, a few chemically stable ones are quantified against certified amino acid reference materials, and the peptide content follows from how many of each residue the sequence contains. The second is the mass balance route above: measure water, counterion, inorganic residue and peptide-related impurities, then subtract the lot from the total. The team behind one set of pharmacopoeial peptide reference standards reported the least inter-laboratory variability from the mass balance approach and use a two-step assignment, establishing a value for bulk material and then assaying the freeze-dried vials against it. The two routes also interact. Work at the international bureau of weights and measures on angiotensin I found that failing to account for peptide-related impurities before assigning a value by amino acid analysis introduces roughly a 1% error in the concentration determined for the peptide in a sample. None of this is a bench-top exercise, and none of it happens without reference materials that a marketing sheet has no access to.^{[2, 4]}

Why the number is usually absent from a research-peptide certificate

A certificate reports the assays somebody commissioned, and the two cheapest useful assays are a chromatographic purity run and a mass check for identity. Net peptide content is neither. It demands either an amino acid analysis with certified standards or a battery of separate determinations across water, counterion, inorganic residue and related impurities, each with its own instrument. A seller under no regulatory obligation publishes what exists. So the absence of a content figure is not evidence that the figure would be bad, and it is certainly not evidence that it would be good. It is an absence, and the honest reading of an absence is that the question was never asked. That is worth saying plainly, because a reader who assumes purity and content are the same number will read a silent certificate as though it answered both. There is a second-order effect too. Purity and content are quoted in the same units and printed in the same font, so a reader comparing two certificates that both say 99% has no way of telling whether the underlying materials differ by ten points of peptide mass or by nothing at all. The comparison feels precise, and it is not.

What the number means, and where this page stops

Net peptide content is a statement about a label and nothing more. It says what fraction of the weight named on that label is peptide rather than counterion, water or salt. Two certificates showing an identical purity percentage can sit on materials whose peptide fractions differ, and no amount of staring at the purity line will tell you which is which. That is the whole of the point, and it is where this page deliberately stops. We do not extend the number into anything downstream, and nothing here should be read as guidance about use of any kind. Research peptides sold online are labelled for laboratory research use only, not for human consumption, and are not FDA-approved for human use. Any question that touches a person rather than a label belongs with a qualified clinician, not with a certificate and not with us.

The one-line version

Purity tells you which peptides are in the sample and in what proportion to each other; net peptide content tells you how much of the material is peptide at all; and a percentage on a product page almost always means the first. The gap between them is counterion, water and residual salt, and in the one well-documented published case above it came to roughly nine percentage points on a sample whose manufacturer reported 98.4%. Knowing that the two numbers exist, and which one you are looking at, is a small piece of literacy that costs nothing. Its companion question, whether the material is even the right molecule, is a separate one entirely and is covered at HPLC vs mass spec. The field-by-field mechanics of the document itself live at how to read a peptide COA.^[1]

References & sources

1. Wang X, Zhang F, Li H, Xiao P, Su F, Xu B, Sun W, Song D. Purity determination of synthetic glucagon using a mass balance approach. Scientific Reports (2020). Reports manufacturer purity 983.72 mg/g and the authors' own LC-UV figure over 970 mg/g against a mass balance content of 896.36 plus or minus 0.68 mg/g; trifluoroacetic acid 103.03 mg/g by ion chromatography, water 50.2 mg/g by Karl Fischer, all inorganic ions under 0.1% by ICP-MS, and nine peptide impurities identified by Orbitrap mass spectrometry.
2. McCarthy D, Han Y, Carrick K, Schmidt D, Workman W, Matejtschuk P, Duru C, Atouf F. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharmaceutical Research 40(6):1317-1328 (2023). Describes a two-step mass balance value assignment for peptide reference standards, separate acetic acid and trifluoroacetic acid content testing, and residual moisture of 1.11 to 2.79 percent w/w across the freeze-dried materials tested; reports least inter-laboratory variability with the mass balance approach.
3. Andrushchenko VV, Vogel HJ, Prenner EJ. Optimization of the hydrochloric acid concentration used for trifluoroacetate removal from synthetic peptides. Journal of Peptide Science 13(1):37-43 (2007). States that trifluoroacetate is almost always present in commercially synthesized peptides.
4. Stoppacher N, Josephs RD, Daireaux A, Choteau T, Westwood SW, Wielgosz RI. Impurity identification and determination for the peptide hormone angiotensin I by liquid chromatography-high-resolution tandem mass spectrometry and the metrological impact on value assignments by amino acid analysis. Analytical and Bioanalytical Chemistry 405(25):8039-8051 (2013). Bureau International des Poids et Mesures; major impurities estimated at 10.4 mg/g, and failure to correct for them would lead to a 1% error in determining the peptide concentration by amino acid analysis.
5. Kaiser E, Rohrer J. Determination of residual trifluoroacetate in protein purification buffers and peptide preparations by ion chromatography. Journal of Chromatography A 1039(1-2):113-117 (2004). Describes the high-capacity anion-exchange ion chromatography method with suppressed conductivity detection used to quantify residual trifluoroacetate in pharmaceutical samples including a commercial peptide.
6. Mant CT, Chen Y, Yan Z, Popa TV, Kovacs JM, Mills JB, Tripet BP, Hodges RS. HPLC Analysis and Purification of Peptides. Methods in Molecular Biology, vol. 386, pp. 3-55 (2007). States that peptide bonds absorb strongly in the far ultraviolet, around 220 nm, which is the basis for the usual 210 to 220 nm detection range.